Skip to main content
. Author manuscript; available in PMC: 2019 Nov 29.
Published in final edited form as: Vaccine. 2018 Nov 3;36(50):7618–7624. doi: 10.1016/j.vaccine.2018.10.091

Figure 4:

Figure 4:

J8 antibody concentration at the final visit, by number of visits (and months) since the last skin infection. Restricted to children not experiencing pharyngitis during the observation period. Boxes represent 25th–75th percentile, solid line the median and dots representing results for individuals. Note that all concurrently infected children had detectable J8 antibody concentrations. Antibody concentrations are provided in ELISA Units (EU).